1606 related articles for article (PubMed ID: 18687247)
1. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
[TBL] [Abstract][Full Text] [Related]
2. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
[TBL] [Abstract][Full Text] [Related]
3. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
[TBL] [Abstract][Full Text] [Related]
4. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC
Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive ventilation outcomes in 2,430 acute decompensated heart failure patients: an ADHERE Registry Analysis.
Tallman TA; Peacock WF; Emerman CL; Lopatin M; Blicker JZ; Weber J; Yancy CW;
Acad Emerg Med; 2008 Apr; 15(4):355-62. PubMed ID: 18370990
[TBL] [Abstract][Full Text] [Related]
6. Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM).
Wong YW; Fonarow GC; Mi X; Peacock WF; Mills RM; Curtis LH; Qualls LG; Hernandez AF
Am Heart J; 2013 Aug; 166(2):349-56. PubMed ID: 23895819
[TBL] [Abstract][Full Text] [Related]
7. Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module).
Diercks DB; Fonarow GC; Kirk JD; Jois-Bilowich P; Hollander JE; Weber JE; Wynne J; Mills RM; Yancy C; Peacock WF;
Am J Cardiol; 2008 Nov; 102(9):1216-9. PubMed ID: 18940295
[TBL] [Abstract][Full Text] [Related]
8. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
[TBL] [Abstract][Full Text] [Related]
9. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
10. Early vasoactive drugs improve heart failure outcomes.
Peacock WF; Emerman C; Costanzo MR; Diercks DB; Lopatin M; Fonarow GC
Congest Heart Fail; 2009; 15(6):256-64. PubMed ID: 19925503
[TBL] [Abstract][Full Text] [Related]
11. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
[TBL] [Abstract][Full Text] [Related]
12. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
[TBL] [Abstract][Full Text] [Related]
13. Primary role of B-type natriuretic peptide across the clinical spectrum: from emergency medicine to transitional care and beyond into the community.
Peacock WF; Piña IL
Congest Heart Fail; 2011; 17(1):8-13. PubMed ID: 21272221
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure.
Wong DT; George K; Wilson J; Manlhiot C; McCrindle BW; Adeli K; Kantor PF
Am J Cardiol; 2011 Feb; 107(4):573-8. PubMed ID: 21295174
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
[TBL] [Abstract][Full Text] [Related]
16. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure.
Horwich TB; Hernandez AF; Dai D; Yancy CW; Fonarow GC
Am Heart J; 2008 Dec; 156(6):1170-6. PubMed ID: 19033015
[TBL] [Abstract][Full Text] [Related]
18. Cardiac troponin and outcome in acute heart failure.
Peacock WF; De Marco T; Fonarow GC; Diercks D; Wynne J; Apple FS; Wu AH;
N Engl J Med; 2008 May; 358(20):2117-26. PubMed ID: 18480204
[TBL] [Abstract][Full Text] [Related]
19. Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE.
Peacock WF; Fonarow GC; Emerman CL; Mills RM; Wynne J; ;
Cardiology; 2007; 107(1):44-51. PubMed ID: 16741357
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE.
Fonarow GC; Peacock WF; Horwich TB; Phillips CO; Givertz MM; Lopatin M; Wynne J;
Am J Cardiol; 2008 Jan; 101(2):231-7. PubMed ID: 18178412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
